Literature DB >> 25106557

Editorial: Signalling pathways in anti-cancer drug resistance.

Chen Chen, Jiezhong Chen, Kong-Nan Zhao1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25106557     DOI： 10.2174/092986732126140804160443

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN： 0929-8673            Impact factor:   4.530


× No keyword cloud information.
  5 in total

1.  miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.

Authors:  Z Zhao; L Zhang; Q Yao; Z Tao
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

Review 2.  Toward a Cancer Drug of Fungal Origin.

Authors:  Alexander Kornienko; Antonio Evidente; Maurizio Vurro; Véronique Mathieu; Alessio Cimmino; Marco Evidente; Willem A L van Otterlo; Ramesh Dasari; Florence Lefranc; Robert Kiss
Journal:  Med Res Rev       Date:  2015-04-08       Impact factor: 12.944

3.  High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.

Authors:  Vibeke Andersen; Lotte K Vogel; Tine Iskov Kopp; Mona Sæbø; Annika W Nonboe; Julian Hamfjord; Elin H Kure; Ulla Vogel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  Death receptor 5 expression is inversely correlated with prostate cancer progression.

Authors:  Angeles Hernandez-Cueto; Daniel Hernandez-Cueto; Gabriela Antonio-Andres; Marisela Mendoza-Marin; Carlos Jimenez-Gutierrez; Ana Lilia Sandoval-Mejia; Rosario Mora-Campos; Cesar Gonzalez-Bonilla; Mario I Vega; Benjamin Bonavida; Sara Huerta-Yepez
Journal:  Mol Med Rep       Date:  2014-08-21       Impact factor: 2.952

5.  BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide.

Authors:  Chien-Min Chen; Jhih-Pu Syu; Tzong-Der Way; Li-Jiau Huang; Sheng-Chu Kuo; Chung-Tien Lin; Chih-Li Lin
Journal:  Int J Mol Med       Date:  2015-09-01       Impact factor: 4.101
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.